No sooner had Goldman Sachs Group Inc. locked in top billing for the SpaceX IPO than Morgan Stanley dashed off a note to ...

Rocket Lab (RKLB) stock just earned a rare vote of confidence from Morgan Stanley. The big bank upgraded the space stock to Overweight and tweaked its price target to $105 from $67. Though that’s a ...

Fintel reports that on September 29, 2025, Morgan Stanley maintained coverage of Rocket Companies (NYSE:RKT) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 11.65% Downside As of ...

Fintel reports that on November 12, 2025, Morgan Stanley maintained coverage of Rocket Lab (NasdaqCM:RKLB) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 18.28% Upside As of ...

Rocket Lab Corporation (NASDAQ:RKLB) rose 5.6% in early trading on Monday after Morgan Stanley issued positive comments on the space launch company and matched the highest price target on the Street.

Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) is one of the best single digit stocks to buy according to analysts. On January 8, Morgan Stanley lowered its price target for Rocket Pharmaceuticals from $7 ...

Morgan Stanley just quadrupled its price target on Rocket Lab stock. The analyst calls Rocket Lab an early version of SpaceX. However, Rocket Lab stock costs 3x what SpaceX did at this stage in SpaceX ...

Morgan Stanley reckons the next AI jump is about to land like a brick through a window. In a new report, the bank says a massive breakthrough is likely in the first half of 2026, and most of the ...

Fintel reports that on January 16, 2026, Morgan Stanley upgraded their outlook for Rocket Lab (NasdaqCM:RKLB) from Equal-Weight to Overweight. As of January 14, 2026, the average one-year price target ...

Rocket Lab has been one of the stronger names in the space sector this year, with the stock up 82% year to date. Rocket Lab has also faced questions about its valuation and the timing of its Neutron ...